Company Search:
Advanced Search
Sponsored Links
Seattle Genetics, Inc. Company Snapshot
Seattle Genetics, Inc. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Seattle Genetics with three other companies in this sector in the United States: BIO-TECHNE Corp (2018 sales of $642.99 million of which 66% was Biotechnology), Acorda Therapeutics, Inc. ($471.43 million of which 98% was Net product revenues), and ALK-Abello A/S ($460.77 million of which 61% was SCIT/SLIT drops).

Sales Analysis. During the year ended December of 2018, sales at Seattle Genetics were $654.70 million. This is an increase of 35.8% versus 2017, when the company's sales were $482.25 million. This was the fifth consecutive year of sales increases at Seattle Genetics (and since 2013, sales have increased a total of 143%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Seattle Genetics, Inc.
  Stock Performance Chart for Seattle Genetics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (10/18/2019): 87.40
(Figures in U.S. Dollars)
1 Week 5.8%   13 Weeks 18.1%  
4 Weeks 16.4%   52 Weeks 21.7%  
Seattle Genetics, Inc. Key Data:
  Ticker: SGEN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 654,700,000
(Year Ending Jan 2019).
Employees: 1,302
  Currency: U.S. Dollars Market Cap: 14,751,437,288
  Fiscal Yr Ends: December Shares Outstanding: 168,780,747
  Share Type: Common Closely Held Shares: 1,423,259
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.